COST NOTES

Ask for
the whole bill.

Put the medicine, the care fee, and the costs outside a plan on the same sheet. Then ask which parts change after the opening offer.

Build my cost questions

Line drawing of an open cost notebook with blank rows, a pencil, and a coral bookmark. — Ask for answers you can keep.

A STARTING POINT, WITH TERMS

What can the medicine cost?

There is no useful single price for “peptide therapy.” Ask for a quote for the exact product and the care around it.

Self-pay means you pay for the medicine without using insurance.

For semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound), many self-pay offers span $149–$499 per monthly supply, as of September 26, 2026.

For certain prescribed strengths of tirzepatide (Zepbound) in small bottles called vials or the injection device called KwikPen, the maker’s Self-Pay Journey Program offers a discount, as checked September 26, 2026.

The discount applies to the first purchase at that strength or a refill purchase within 45 days of the last delivery, as checked September 26, 2026.

Missing the deadline can raise the medicine price to $699, depending on your prescribed strength, as checked September 26, 2026.

Look for “Self-Pay Journey Program” on your quote. Ask whether your prescribed strength gets that discount, what date your refill is due, and what you will pay if you miss it.

The range includes starting offers and varies by medicine, strength, and refill terms.

These are medicine prices; a care membership and tests may add to the bill.

As checked September 26, 2026, a Zepbound month means 28 days of medicine.

For semaglutide (Wegovy), a month means a box of four injection pens or a bottle of 30 tablets, as checked September 26, 2026.

For semaglutide (Ozempic) shots, the maker calls a box with one injection pen a month’s supply, as checked September 26, 2026.

Ask for the number of pens, bottles, or tablets, how many days the medicine will last, and how often you will be charged.

Basis: the makers’ published self-pay terms.

Many savings-card and cash-offer terms expire on December 31, 2026, as checked September 26, 2026.

Get the offer’s end date in the written quote.

Will insurance pay?

Start with the exact drug and the reason it is prescribed. Ask your plan about its list of covered medicines and any approval needed before it pays.

Medicare drug plans can cover some of these medicines for another health problem, such as type 2 diabetes, as of September 26, 2026.

Another possible use is lowering heart-attack and stroke risk in people with heart disease and excess weight, as of September 26, 2026.

That still depends on the plan’s covered-drug list and any prior approval it requires.

Prior authorization is the insurer’s step for agreeing to pay in advance.

Medicare’s drug-coverage guidance

A separate Medicare route

The temporary Medicare GLP-1 Bridge offers a $50 monthly supply of listed weight-loss medicines to people who meet its rules, as of September 26, 2026.

Your body uses a hormone called GLP-1 as a chemical messenger to help control blood sugar and appetite.

GLP-1 medicines copy the action of that messenger.

The programme starts July 1, 2026; its final day is December 31, 2027.

Who can use the offer?

You need a separate Medicare Part D drug plan or a qualifying Medicare Advantage health plan with drug coverage, as of September 26, 2026.

Part D is Medicare’s prescription-drug insurance. Medicare Advantage is a way to get Medicare health coverage through a private plan. Ask your plan whether its type can use the Bridge.

You must be at least 18 and meet one of the following health rules, judged when GLP-1 treatment began, as of September 26, 2026.

BMI, or body mass index, compares your weight with your height. Your prescriber can work it out.

A BMI of 35 or higher meets the weight rule.
A BMI of 30 or more can qualify with a type of heart failure called “preserved ejection fraction,” meaning a normal share of blood is still pumped out.
At that BMI, kidney disease at stage 3a or later also qualifies.
High blood pressure also qualifies at that BMI when two blood-pressure medicines still leave the top reading above 140 or the bottom reading above 90.
A BMI of 27 or more can qualify with prediabetes or a previous stroke or heart attack. Artery disease with symptoms in your legs or arms also qualifies at that BMI.

With prediabetes, blood sugar is higher than normal but has not reached the diabetes range. Ask your clinician which heart or kidney diagnosis is in your record.

People with type 2 diabetes or moderate or severe sleep apnea cannot use the Bridge, as of September 26, 2026.

Sleep apnea means breathing repeatedly stops during sleep.

Another excluded group has MASH, liver inflammation linked to fat buildup, with moderate or advanced liver scarring but no cirrhosis, as of September 26, 2026.

Cirrhosis is a late stage of liver scarring. Ask your clinician which diagnosis is in your record; this exclusion does not apply to every fatty-liver diagnosis.

These uses follow the usual Part D coverage route, along with prescriptions aimed at reducing the risk of a heart attack or stroke, as of September 26, 2026.

If Part D made a payment in 2026 for your GLP-1 medicine, you cannot use the Bridge that year, as checked September 26, 2026.

The Bridge also calls for a prescription and a continuing plan for food choices and physical activity, with approval needed before payment, as of September 26, 2026.

Which medicines count?

As checked September 26, 2026, the list includes orforglipron (Foundayo) tablets, semaglutide (Wegovy) shots or tablets, and tirzepatide (Zepbound) only in the device called KwikPen.

Zepbound in single-dose pens or vials is excluded from the Bridge, as checked September 26, 2026.

Under the programme, the monthly payment does not count toward your Medicare drug plan’s yearly cap on what you pay.

This programme provides no added help with payments for people on low incomes.

Ask your prescriber to match your health record, plan type, and exact medicine to these rules before relying on the price.

Medicare’s Bridge programme details

YOUR COST QUESTION SHEET

What is still missing from the quote?

Choose what the offer tells you. Use the questions that follow when talking to the service or your insurer.

Price is one part of the decision.

Keep the written quote with the follow-up plan and the names of both the clinician and the pharmacy. A missing answer stays a missing answer, however appealing the price looks.

Return to the Missouri care checklist